The Byers Eye Institute at Stanford University is dedicated to combating blindness and preserving sight. We deliver effective, integrated vision care across all specialties from one state-of-the-art, patient-centered facility in Palo Alto, California.


Our premier group of visionary scientists is leading innovations in diagnostics and the next generation of vision restorative therapeutics. Stanford's vision research faculty bring the latest in basic and translational research as well as clinical trials.


Residency training and clinical and research fellowships at Stanford in Retina, Glaucoma, Cornea, Oculoplastics, Pediatrics and Neuro-Ophthalmology, as well as special fellowships in international health and ophthalmic innovation, together offer exciting opportunities to advance the field and develop careers. 


Jeffrey L. Goldberg, MD, PhD
Professor and Chairman
Department of Ophthalmology

Welcome to the Byers Eye Institute in the Department of Ophthalmology, at Stanford University School of Medicine, a top-tier, internationally recognized, multidisciplinary center combining world-class resources with a commitment to providing the highest level of diagnostic and therapeutic care to our patients.

Through an integrated, personalized approach to healthcare delivery, our dedicated team provides the latest therapies in treating eye disorders. Associated with Stanford Health Care, and the Lucille-Packard Children's Hospital, our faculty and staff provide excellence in ocular and vision healthcare to patients across Northern California and from around the world, while our cutting-edge team of researchers carries out some of the most innovative laboratory research and clinical trials anywhere.

Whether you are a patient, a resident, or a leader in academic or clinical ophthalmology, I invite you to explore our programs, visit our clinics and operating rooms, and receive your eye care from our premier faculty.

I am very proud of our exceptional faculty and staff and their accomplishments in our mission areas of patient care, research, education and community outreach. 

We are here for you.


We are searching for the best clinicians, clinician-scientists, and vision research scientists to join our faculty at Stanford. If you are looking for staff positions in administration or laboratory or clinical research, please follow this link.

In the News

Listen Now: Dr. Jeffrey Goldberg, chair of Ophthalmology at Stanford, on the Huberman Podcast

Learn about eye care at all ages — from infant to adult and as we age — as well as the latest in research to protect and improve our vision, and exciting initiatives at the Byers Eye Institute.

Ocular Melanoma 5K Benefit Returns July 15

The annual race hosted at the Byers Eye Institute at Stanford aims to raise awareness about ocular melanoma.

Mid-year check-in with Dr. Jeffrey Goldberg, Chair of Ophthalmology at Stanford

During Dr. Goldberg's tenure as chair, the team at the Byers Eye Institute has grown significantly.

Dr. Kuldev Singh makes 2023 Power List

The list highlights the 100 most influential and inspirational people in ophthalmology.

Dr. Arthur Brant, Byers Eye Institute Resident, wins prestigious Rosenkranz Prize

Dr. Brant intends to use his $100,000 prize to work on finding a safe and practical solution to prevent blindness — with the goal of eliminating blindness from sickle cell in West Africa. 

Kicking off Stanford’s SIGHT Glaucoma Registry

Stanford Ophthalmology is leading a pacesetting effort to uncover new glaucoma biomarkers, a key challenge to discovering new breakthroughs in fighting the blinding disease. 

Multidisciplinary team develops new CRISPR platform for gene therapy

Gene therapy, in conjunction with the disruptive technology called Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), has the potential to revolutionize the treatment of previously incurable eye diseases.

How Vision Loss Helped Me See the World in a New Light

In my dreams I was always healthy. In my dreams I could still see, I could drive at night, I could devour books with impunity, and I could pursue goals without constraint.

New drug gives patient his sight back

When Gang Pan first came to Stanford Medicine, he could no longer work or drive and was uncomfortable even venturing out in public because an autoimmune condition had severely restricted his vision and the movement of his eyes.

The Stanford Ophthalmology 2022 Annual Report highlights the department's recent news and accomplishments. Click here to read or download the PDF.

The recent issue of Stanford Medicine magazine, a theme issue on eyes and vision, includes details about projects and others pushing the boundaries of biology and technology to help people see.  Click here to learn more

Illustration by John Hersey